SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): June 18, 2009
INVENTIV HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE
(State or Other Jurisdiction of Incorporation)
0-30318 ; 52-2181734
(Commission File Number) (I.R.S. Employer Identification No.)
VANTAGE COURT NORTH
200 COTTONTAIL LANE
SOMERSET, NEW JERSEY 08873
(Address of Principal Executive offices) (Zip Code)
(800) 416-0555
(Registrant's Telephone Number, Including Area Code
N/A
(Former Name or Former Address, if changed Since Last Report)
INVENTIV HEALTH, INC.
CURRENT REPORT ON FORM 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On June 18, 2009, the Registrant adopted revised forms of award notices for restricted stock and stock option grants to directors, which are attached to this report as Exhibits 10.1 and 10.2, respectively. The revised award notices provide for acceleration of vesting upon a change in control, death or disability while serving as a director.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit 10.1 Form of Director Restricted Stock Award Notice.
Exhibit 10.2 Form of Director Option Award Notice.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | INVENTIV HEALTH, INC. | |
| | | | |
| Date: June 22, 2009 | By: | /s/ David Bassin | |
| | | Name: David Bassin | |
| | | Title: Chief Financial Officer and Secretary | |
| | | | |
